Antivert and Tracleer drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Antivert (meclizine hydrochloride) and Tracleer (bosentan). Common drug interactions include dyspnoea among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Antivert and Tracleer. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Antivert?

Antivert has active ingredients of meclizine hydrochloride. It is often used in dizziness. eHealthMe is studying from 4,087 Antivert users. Check the latest studies of Antivert.

What is Tracleer?

Tracleer has active ingredients of bosentan. It is often used in primary pulmonary hypertension. eHealthMe is studying from 55,125 Tracleer users. Check the latest studies of Tracleer.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

15 people who take Antivert and Tracleer together, and have interactions are studied.

Antivert and Tracleer drug interactions.

What are the common drug interactions of Antivert and Tracleer, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Oedema peripheral (superficial swelling)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Abdominal distension
  5. Cardiac failure congestive
  6. Dyspnoea exertional (breathlessness or shortness of breath)
  7. Fall
  8. Oedema (fluid collection in tissue)
  9. Weight increased
  10. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Blood chloride decreased
  3. Hypotension (abnormally low blood pressure)
  4. Neck pain
  5. Renal failure (kidney dysfunction)
  6. Visual impairment
  7. Nausea (feeling of having an urge to vomit)
  8. Pancreatitis (inflammation of pancreas)
  9. Pneumonia
  10. Asthenia (weakness)

What are the common drug interactions of Antivert and Tracleer, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Confusional state
  3. Cystitis interstitial (unknown cause characterized by bladder pain)
  4. Fall
  5. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  6. Abortion spontaneous (naturally occurring miscarriage)
  7. Maternal exposure during pregnancy (use of substance during pregnancy)

40-49:

n/a

50-59:

n/a

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Fluid overload (too much fluid in the blood)
  3. Blood urea increased
  4. Eye movement disorder
  5. General physical health deterioration (weak health status)
  6. Hypotension (abnormally low blood pressure)
  7. Neck pain
  8. Visual impairment
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Abdominal distension

What are the existing conditions these people have? *

  1. Seasonal Allergy (allergic condition due to certain season): 2 people, 13.33%
  2. Pulmonary Hypertension Primary (increase in blood pressure in the lung artery with no cause): 2 people, 13.33%
  3. Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 13.33%
  4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Antivert and Tracleer?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Antivert and Tracleer:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Antivert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tracleer:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Antivert and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tracleer and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on meclizine hydrochloride and bosentan (the active ingredients of Antivert and Tracleer, respectively), and Antivert and Tracleer (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: